direct,indirect,issuer_cik,issuer_name,isDirector,isOfficer,isTenPercentOwner,isOther,date,name,accession,officerTitle,predicted_gender,total_stock
20000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100111,swartz eric s,101968710000091,,male,
40000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100112,swartz eric s,101968710000109,,male,
60000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100119,swartz eric s,101968710000198,,male,
29028.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20100203,fussey shelley pm,101968710000393,"VP, Intellectual Property",female,
25436.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20100203,shan joseph,101968710000394,VP Clinical/Regulatory Affairs,male,
60367.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20100203,lytle paul j,101968710000395,Chief Financial Officer,male,
88311.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20100203,king steven w,101968710000396,President & CEO,male,
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100203,pohl david,101968710000397,,male,
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100203,johnson carlton m,101968710000398,,male,
0.0,167739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100203,swartz eric s,101968710000399,,male,
78000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100208,swartz eric s,101968710000455,,male,
95700.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100218,swartz eric s,101968710000667,,male,
100000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20100219,swartz eric s,101968710000692,,male,
65367.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20100924,lytle paul j,101968710003462,Chief Financial Officer,male,
93311.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20100924,king steven w,101968710003461,President & CEO,male,
72051.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20100927,lytle paul j,101968710003474,Chief Financial Officer,male,
110000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20101109,swartz eric s,101968710003991,,male,
24028.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110104,fussey shelley pm,101968711000030,"V.P., Intellectual Property",female,
79311.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20110104,king steven w,101968711000031,President & CEO,male,
63051.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110104,lytle paul j,101968711000032,Chief Financial Officer,male,
20436.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110104,shan joseph,101968711000033,VP Clinical/Regulatory Affairs,male,
29028.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110211,fussey shelley pm,101968711000487,"V.P., Intellectual Property",female,
93311.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20110211,king steven w,101968711000491,President & CEO,male,
72051.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110211,lytle paul j,101968711000492,Chief Financial Officer,male,
25436.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110211,shan joseph,101968711000493,"VP, Clinical/Regulatory Affair",male,
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20110503,swartz eric s,101968711001440,,male,69837142.0
15436.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110503,shan joseph,101968711001439,V.P. Clinical & Reg. Affairs,male,69837142.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20110503,pohl david,101968711001438,,male,69837142.0
68357.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20110503,king steven w,101968711001436,President & CEO,male,69837142.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20110503,johnson carlton m,101968711001435,,male,69837142.0
24399.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110503,fussey shelley pm,101968711001434,"V.P., Intellectual Property",female,69837142.0
59998.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110503,lytle paul j,101968711001437,Chief Financial Officer,male,69837142.0
14399.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110705,fussey shelley pm,101968711002168,"V.P., Intellectual Property",female,69837142.0
40357.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20110705,king steven w,101968711002169,President & CEO,male,69837142.0
41998.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110705,lytle paul j,101968711002170,Chief Financial Officer,male,69837142.0
5436.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20110705,shan joseph,101968711002171,"VP, Clinical and Reg Affairs",male,69837142.0
24521.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20111102,fussey shelley pm,101968711003337,"V.P., Intellectual Property",female,82638201.0
59161.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20111102,king steven w,101968711003338,President & CEO,male,82638201.0
56120.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20111102,lytle paul j,101968711003339,Chief Financial Officer,male,82638201.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20120221,king steven w,101968712000624,President & CEO,male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120221,shan joseph,101968712000628,"V.P., Clinical & Reg. Affairs",male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120221,masten jeffrey l.,101968712000627,V.P. Quality,male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120221,lytle paul j,101968712000626,Chief Financial Officer,male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120221,pohl david,101968712000622,,male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120221,johnson carlton m,101968712000623,,male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120221,swartz eric s,101968712000621,,male,93146226.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120221,fussey shelley pm,101968712000625,"V.P., Intellectual Property",female,93146226.0
126000.0,107739.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120315,swartz eric s,101968712000956,,male,98873172.0
12498.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120501,masten jeffrey l.,101968712001564,V.P. Quality,male,101421365.0
37019.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120501,fussey shelley pm,101968712001559,"V.P., Intellectual Property",female,101421365.0
69887.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20120501,king steven w,101968712001560,President & CEO,male,101421365.0
68618.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120501,lytle paul j,101968712001561,Chief Financial Officer,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120508,shan joseph,101968712001689,"VP, Clinical and Reg Affairs",male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120508,pohl david,101968712001688,,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120508,swartz eric s,101968712001690,,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120508,masten jeffrey l.,101968712001687,V.P. Quality,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20120508,johnson carlton m,101968712001684,,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20120508,king steven w,101968712001685,President & CEO,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120508,lytle paul j,101968712001686,Chief Financial Officer,male,101421365.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20120508,fussey shelley pm,101968712001683,"V.P., Intellectual Property",female,101421365.0
54999.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121101,fussey shelley pm,101968712003840,"V.P., Intellectual Property",female,123310188.0
89503.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121101,lytle paul j,101968712003842,Chief Financial Officer,male,123310188.0
80887.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20121101,king steven w,101968712003844,President & CEO,male,123310188.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121228,ziebell mark r,101968712004679,"V.P., General Counsel",male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20121228,swartz eric s,101968712004678,,male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121228,shan joseph,101968712004677,"VP, Clinical and Reg Affairs",male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20121228,pohl david,101968712004676,,male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121228,masten jeffrey l.,101968712004675,V.P. Quality,male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121228,lytle paul j,101968712004674,Chief Financial Officer,male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20121228,king steven w,101968712004673,President & CEO,male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20121228,johnson carlton m,101968712004672,,male,132539783.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20121228,fussey shelley pm,101968712004671,"V.P., Intellectual Property",female,132539783.0
65480.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130501,fussey shelley pm,101968713001577,"V.P., Intellectual Property",female,143768946.0
87403.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20130501,king steven w,101968713001578,President & CEO,male,143768946.0
101491.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130501,lytle paul j,101968713001579,Chief Financial Officer,male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130508,ziebell mark r,101968713001690,"V.P., General Counsel",male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130508,shan joseph,101968713001688,"VP, Clinical and Reg Affairs",male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20130508,pohl david,101968713001687,,male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130508,masten jeffrey l.,101968713001686,V.P. Quality,male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20130508,swartz eric s,101968713001689,,male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20130508,king steven w,101968713001684,President & CEO,male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20130508,johnson carlton m,101968713001683,,male,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130508,fussey shelley pm,101968713001682,"V.P., Intellectual Property",female,143768946.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20130508,lytle paul j,101968713001685,Chief Financial Officer,male,143768946.0
187403.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20131017,king steven w,101968713003917,President & CEO,male,156461114.0
169892.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20140501,king steven w,101968714001631,President & CEO,male,178871164.0
78803.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20140501,fussey shelley pm,101968714001632,"V.P., Intellectual Property",female,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20140508,ziebell mark r,101968714001725,"V.P., General Counsel",male,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20140508,swartz eric s,101968714001723,,male,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20140508,shan joseph,101968714001722,"V.P., Clinical and Reg Affairs",male,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20140508,pohl david,101968714001724,,male,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20140508,king steven w,101968714001715,President & CEO,male,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20140508,johnson carlton m,101968714001714,,male,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20140508,fussey shelley pm,101968714001712,"V.P., Intellectual Property",female,178871164.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20140508,lytle paul j,101968714001716,Chief Financial Officer,male,178871164.0
84165.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20141104,fussey shelley pm,101968714004045,"V.P., Intellectual Property",female,182000583.0
173172.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20141104,king steven w,101968714004046,President & CEO,male,182000583.0
177806.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20150501,king steven w,101968715001719,President & CEO,male,193346627.0
106708.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20150501,lytle paul j,101968715001720,Chief Financial Officer,male,193346627.0
91344.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20150501,fussey shelley pm,101968715001718,"V.P., Intellectual Property",female,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20150512,swartz eric s,101968715001889,,male,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20150512,fussey shelley pm,101968715001883,"V.P., Intellectual Property",female,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20150512,johnson carlton m,101968715001884,,male,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,1,0.0,0.0,20150512,king steven w,101968715001885,President & CEO,male,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20150512,lytle paul j,101968715001886,Chief Financial Officer,male,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,1,0,0.0,0.0,20150512,pohl david,101968715001887,,male,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20150512,shan joseph,101968715001888,"VP, Clinical and Reg Affairs",male,193346627.0
0.0,0.0,704562,peregrine pharmaceuticals inc,0,1,0.0,0.0,20150512,ziebell mark r,101968715001890,"V.P., General Counsel",male,193346627.0
